TASLY(SH:600535) Huan Qiu Lao Hu Cai Jing·2025-04-10 09:19Group 1: Event Overview - The 2025 Wuzhen Health Conference and the 4th OTC Conference opened on April 9, showcasing the health industry with various forums and discussions on policies, trends, and dynamics [1] - The event featured multiple segments including the 4th OTC Conference, Traditional Chinese Medicine Anti-Aging Conference, and Digital Health Industry Conference, promoting diverse exchanges and sharing [1] Group 2: Company Showcase - Tianshili set up an independent exhibition booth, creatively designed to blend modern technology with traditional Chinese medicine culture, showcasing its star products in cardiovascular, oncology, digestive metabolism, and neuroscience [3] - The innovative health product display area featured health drinks and nutritional supplements tailored for different age groups, attracting health-conscious consumers [5] Group 3: Thematic Meetings - Tianshili held a special presentation titled "Project Upgrade + Category Innovation to Build a New Engine for OTC Market Growth," emphasizing its commitment to OTC market development and innovation [6] - The presentation included insights on the impact of policy on the nutritional supplement market and Tianshili's innovative growth paths, with attendees actively engaging and taking notes [6][7] Group 4: Networking and Collaboration - The "Tianshili Night" event provided a relaxed atmosphere for business discussions, allowing clients to share market feedback and needs while Tianshili's staff listened and responded [8] - The company aims to foster collaboration and mutual understanding, laying a solid foundation for future partnerships [8] Group 5: Industry Significance - Tianshili's performance at the Wuzhen Health Conference is significant amid challenges like strict regulations and intensified market competition, showcasing its innovative approaches in product development and marketing [10] - The company is committed to collaboration and shared market opportunities, driving continuous growth in the OTC market [10]